UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000060496
Receipt number R000069208
Scientific Title Effect of Digital Device Interventions on Insomnia Symptoms among Working Women during Menopause: A Randomized Controlled Trial
Date of disclosure of the study information 2026/01/28
Last modified on 2026/01/28 12:47:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of Digital Device Interventions on Insomnia Symptoms among Working Women during Menopause: A Randomized Controlled Trial

Acronym

Effect of Digital Device Interventions on Insomnia Symptoms among Working Women during Menopause: A Randomized Controlled Trial

Scientific Title

Effect of Digital Device Interventions on Insomnia Symptoms among Working Women during Menopause: A Randomized Controlled Trial

Scientific Title:Acronym

Effect of Digital Device Interventions on Insomnia Symptoms among Working Women during Menopause: A Randomized Controlled Trial

Region

Japan


Condition

Condition

Insomnia Symptoms

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to investigate the effectiveness of digital CBT-based and mindfulness-based interventions among perimenopausal women

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Insomnia Severity Index: ISI

Key secondary outcomes

1. Pittsburgh Sleep Quality Index: PSQI
2. Menopause Rating Scale: MRS
3. Work Functioning Impairment scale: WFun
4. Generalized Anxiety Disorder-7: GAD-7
5. Patient Health Questionnaire-9: PHQ-9
6. Five Facet Mindfulness Questionnaire: FFMQ
7. Cognitive Fusion Questionnaire: CFQ-7


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Behavior,custom

Interventions/Control_1

Intervention using a Sleep diary integrated CBTI based application.
The sleep coaching program consists of a total of 26 tasks, including cognitive behavioral therapy components such as stimulus control and sleep restriction, stress reduction components such as relaxation, and sleep hygiene components. Participants select three tasks from the presented options and focus on them for four weeks. Each day, they report whether the tasks were implemented and record their sleep status using a sleep diary, including bedtime and wake-up time, sleep onset latency, nocturnal awakenings, and daytime vitality.

Interventions/Control_2

Duration: 4 weeks (28 days), approximately 5-10 minutes per day
Overall structure: A stepwise mindfulness program progressing from awareness of attention to meditation practice and generalization to daily life

Days 1-7 (Introduction and attention training)
Psychoeducation on the vicious cycle between menopausal symptoms and insomnia
Awareness of being caught up in thoughts and guided attention training (audio-based)

Days 8-15 (Meditation introduction)
Introduction of a three-step meditation (breath, bodily sensations, thoughts/emotions)

Days 16-21 (Meditation application)
Application of the three-step meditation in bedtime situations

Days 22-28 (Generalization to daily life)
Mindfulness practice during everyday activities (e.g., walking, household tasks)

Interventions/Control_3

Control group:
Use a sleep diary to record sleep status, including bedtime and wake-up time, sleep onset latency, awakenings during the night, and daytime energy levels.

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

45 years-old <=

Age-upper limit

55 years-old >=

Gender

Female

Key inclusion criteria

1. Presence of at least mild menopausal symptoms: total MRS score >= 5
2. Presence of at least mild insomnia symptoms: ISI score >= 8
3. Not taking prescription hypnotics from medical institutions
4. Not taking over-the-counter sleep aids

Key exclusion criteria

1. History of post-traumatic stress disorder (PTSD) or depressive disorders (including suicidal ideation)
2. Sleep disorders other than insomnia (e.g., restless legs syndrome, sleep apnea syndrome)
3. Currently receiving pharmacotherapy with hypnotics or psychotherapy for sleep problems
4. Shift work employment
5. High risk of serious consequences due to sleep deprivation (e.g., truck drivers)
6. Major life events within the past month (e.g., hospitalization, bereavement)
7. Presence of systemic underlying diseases such as cancer or intractable disorders
8. History of surgical menopause or premature menopause

Target sample size

900


Research contact person

Name of lead principal investigator

1st name Kyoko
Middle name
Last name Nomura

Organization

Akita University

Division name

Department of Environmental Health Science and Public Health, Graduate School of Medicine

Zip code

0108543

Address

1-1-1, Hondo, Akita-shi, Akita

TEL

018-884-6087

Email

knomura@med.akita-u.ac.jp


Public contact

Name of contact person

1st name Songee
Middle name
Last name Jung

Organization

Akita University

Division name

Department of Environmental Health Science and Public Health, Graduate School of Medicine

Zip code

0108543

Address

1-1-1, Hondo, Akita-shi, Akita

TEL

018-884-6087

Homepage URL


Email

jonsoni@med.akita-u.ac.jp


Sponsor or person

Institute

Akita University

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development (AMED)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of Akita University Graduate School of Medicine and Faculty of Medicine

Address

1-1-1, Hondo, Akita-shi, Akita 010-8543

Tel

018-801-7127

Email

soken@hos.akita-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 01 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 11 Month 11 Day

Date of IRB

2026 Year 01 Month 14 Day

Anticipated trial start date

2026 Year 06 Month 01 Day

Last follow-up date

2026 Year 10 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 01 Month 28 Day

Last modified on

2026 Year 01 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000069208